How adverse event reporting in the Slovak Republic is influenced by nurse characteristics and working arrangements: a cross-sectional study

Background Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls. Methods We performed a questionnaire survey for nursing staff in our hospital from April to May 2021. Based on baseline characteristics, we divided the participants into migraine, non-migrainous headache, and healthy control, and examined the occurrence and features of headache after COVID-19 vaccinations. Results We included 171 participants (15.2% migraine and 24.6% non-migrainous headache). Headache incidence after vaccinations was significantly higher in the migraine (69.2%) and non-migrainous headache (71.4%) groups than in the healthy control (37.9%) group. The incidence of headaches was significantly higher after the second dose compared to the first (45.6% vs. 20.5%). Conclusion Migraineurs and non-migrainous headache participants developed more headaches compared to the healthy controls after COVID-19 vaccination.

Download Full-text

Supporting health professionals after an adverse event in Swiss hospitals: a cross-sectional study

Swiss Medical Weekly ◽

10.4414/smw.2020.20278 ◽

2020 ◽

Author(s):

Franziska Reiser Crelier ◽

David Schwappach ◽

Ren Schwendimann

Keyword(s):

Adverse Event ◽

Health Professionals ◽

Cross Sectional Study ◽

Sectional Study ◽

Cross Sectional

Download Full-text

Adverse event reporting in Slovenia - the influence of safety culture, supervisors and communication

Vojnosanitetski pregled ◽

10.2298/vsp141231137b ◽

2016 ◽

Vol 73 (8) ◽

pp. 714-722

Author(s):

Karin Birk ◽

Ljubisa Padjen ◽

Mirko Markic

Keyword(s):

Adverse Event ◽

Safety Culture ◽

Adverse Event Reporting ◽

Point Of View ◽

University Hospital ◽

Cross Sectional ◽

Event Reporting ◽

Eu Member States ◽

Preventative Measures ◽

Sectional Analysis

Background/Aim. The provision of safe healthcare is considered a priority in European Union (EU) member states. Along with other preventative measures in healthcare, the EU also strives to eliminate the ?causes of harm to human health?. The aim of this survey was to determine whether safety culture, supervisors and communication between co-workers influence the number of adverse event reports submitted to the heads of clinical departments and to the management of an institution. Methods. This survey is based on cross-sectional analysis. It was carried out in the largest Slovenian university hospital. We received 235 completed questionnaires. Respondents included professionals in the fields of nursingcare, physiotherapy, occupational therapy and radiological technology. Results. Safety culture influences the number of adverse event reports submitted to the head of a clinical department from the organizational point of view. Supervisors and communication between co-workers do not influence the number of adverse event reports. Conclusion. It can be concluded that neither supervisors nor the level of communication between co-workers influence the frequency of adverse event reporting, while safety culture does influence it from an organizational point of view. The presumed factors only partly influence the number of submitted adverse event reports, thus other causes of under-reporting must be sought elsewhere.

Download Full-text

Assessment of adverse event following immunization and its co-relates among COVID-19 vaccine recipient in Bundelkhand region of Uttar Pradesh: A cross-sectional study

Indian Journal of Community Health ◽

10.47203/ijch.2021.v33i02.027 ◽

2021 ◽

Vol 33 (2) ◽

pp. 379-382

Author(s):

Suneel Kumar Kaushal ◽

Ashok Kumar Patel ◽

Mukesh Yadav ◽

Navin Kumar

Keyword(s):

Adverse Event ◽

Uttar Pradesh ◽

Vaccine Recipient ◽

Cross Sectional Study ◽

Risk Profile ◽

Sectional Study ◽

Cross Sectional ◽

Serious Adverse Event ◽

Adverse Event Following Immunization ◽

Good Safety Profile

Background: The COVID-19 pandemic is a global emergency. AEFIs reporting and assessment should be done with high priority as they could change the benefit-risk profile of the vaccine. Objective: To assess adverse effects after COVID-19 vaccination. Methods: This cross-sectional study conducted among 605 heath functionaries taken part from January 2021 to March 2021. Results: The most common AEFI reported was pain at injection site (51.9%). Gender, previous COVID status and perception before vaccination were significantly associated with AEFI. Conclusion: There was no serious adverse event after vaccination. COVID vaccine has a good safety profile.

Download Full-text

Adverse event of antiepileptic drugs: a cross sectional study

MATEC Web of Conferences ◽

10.1051/matecconf/201819707004 ◽

2018 ◽

Vol 197 ◽

pp. 07004

Author(s):

P A N K Permatananda ◽

E Kristin ◽

D Endharti ◽

R T Pinzon ◽

I K Sumada

Keyword(s):

Adverse Effect ◽

Adverse Event ◽

Statistical Analysis ◽

Common Adverse Effect ◽

Cross Sectional Study ◽

P Value ◽

Sectional Study ◽

Chi Square ◽

Cross Sectional ◽

Chi Square Test

Epilepsy is a major non-communicable disorder. Choice between switching to another drug and combining is still debatable when the first antiepileptic drug is ineffective in controlling seizure. Polytherapy usually related with the appearance of adverse effect. This cross sectional study was conducted in Neurology Policlinic with 83 epilepsy patients, consisting of 37 patients used monotherapy and 46 patients used polytherapy. The most common adverse effect was fatigue. Statistical analysis using chi square test showed statistically significant between monotherapy and polytherapy patients against fatigue (p value >0.05). In conclusion, polytherapy is related with the appearance of adverse effect in epilepsy patients.

Download Full-text

Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection

10.1101/2021.07.23.21261029 ◽

2021 ◽

Author(s):

Marie Suehiro ◽

Shinya Okubo ◽

Kensuke Nakajima ◽

Kosuke Kanda ◽

Masanobu Hayakawa ◽

...

Keyword(s):

Adverse Event ◽

Adverse Events ◽

Questionnaire Survey ◽

Cross Sectional Study ◽

Young Population ◽

Sectional Study ◽

Multivariable Logistic Regression Model ◽

Cross Sectional ◽

Vaccination Site ◽

First Time

A cross-sectional study was conducted to clarify the adverse events of COVID-19 vaccines in Japanese young population. The proportion of participants with adverse events at the vaccination site (immediately or within 30 minutes after vaccination) was 0.5%, and anaphylaxis occurred in one female student (0.03%). We analyzed 1,877 data obtained from a questionnaire survey of 1,993 vaccinated individuals. Eighty-two percent of participants complained of local adverse events. Injection site pain was the most common local adverse event (71%). Systemic adverse events occurred in 48% of participants. The most common adverse event was myalgia (34%). A multivariable logistic regression model was used to determine risk factors. Local adverse events were associated with sex (female) and allergy history, with odds ratios (ORs) (95% confidence interval [CI]) of 2.15 (1.69-2.73) and 1.73 (1.10-2.74), respectively. Systemic adverse events were associated with sex (female), age (<20 years old), allergy history, and history of adverse events with previous medications, with ORs (95% CI) of 2.49 (2.03-3.06), 1.80 (1.44-2.24), 1.39 (1.03-1.89), and 1.53 (1.02-2.29). The results of this study clarified for the first time that age less than 20 years is a risk factor for systemic adverse events from the COVID-19 Vaccine Moderna Intramuscular Injection. This information will give impacts on considering adverse events and its mechanisms in mRNA vaccination.

Download Full-text